Filing Details
- Accession Number:
- 0000899866-18-000114
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-07-12 17:23:37
- Reporting Period:
- 2018-07-10
- Accepted Time:
- 2018-07-12 17:23:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 899866 | Alexion Pharmaceuticals Inc. | ALXN | Pharmaceutical Preparations (2834) | 133648318 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1409601 | J Paul Clancy | C/O Alexion Pharmaceuticals, Inc. 121 Seaport Blvd Boston MA 02210 | Evp, Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $.0001 Per Share | Disposition | 2018-07-10 | 5,241 | $131.11 | 93,309 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.
Billionaire Hedge Funds
